These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24146918)

  • 1. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
    Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
    PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
    Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
    J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
    Zhang Y; Feng Y; Chen L; Zhu J
    Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
    Chen YJ; Lam J; Gregory CR; Schrepfer S; Wulff H
    PLoS One; 2013; 8(11):e81006. PubMed ID: 24312257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions.
    Chiang EY; Li T; Jeet S; Peng I; Zhang J; Lee WP; DeVoss J; Caplazi P; Chen J; Warming S; Hackos DH; Mukund S; Koth CM; Grogan JL
    Nat Commun; 2017 Mar; 8():14644. PubMed ID: 28248292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
    Freise C; Querfeld U
    Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
    Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
    Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role and mechanism of K
    Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
    Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two-pore domain K2 P channel TASK2 drives human NK-cell proliferation and cytolytic function.
    Schulte-Mecklenbeck A; Bittner S; Ehling P; Döring F; Wischmeyer E; Breuer J; Herrmann AM; Wiendl H; Meuth SG; Gross CC
    Eur J Immunol; 2015 Sep; 45(9):2602-14. PubMed ID: 26140335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
    Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
    Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
    Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
    PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
    Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
    J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
    Li H; Zhao JL; Zhang YM; Han SX
    Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.
    Kahlfuß S; Simma N; Mankiewicz J; Bose T; Lowinus T; Klein-Hessling S; Sprengel R; Schraven B; Heine M; Bommhardt U
    Mol Cell Biol; 2014 Mar; 34(5):820-31. PubMed ID: 24344200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
    Chen CL; Liao JW; Hu OY; Pao LH
    Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.